UK Central Nervous System Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2503

  • Format: PPT, PDF

UK CNS Therapeutics Market: Segmented by Drug Class (Analgesics, Nervous System Drugs, Anaesthetics, Anti-Parkinson Drugs, Multiple Sclerosis, Anti-Epileptics, Anti-Psychotic) and Distribution Channel (Hospital pharmacies, Retail pharmacies/drug stores and Online/e-Pharmacies) – Growth, Trends, and Forecasts (2019 – 2028)

Clear
SKU: 2503 Categories: ,

Report Overview

The UK CNS Drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The UK’s market for CNS Therapeutics is driven by the urgent need to address the unmet medical needs of neurological disorders. The central nervous system drugs market was mainly driven by rapid growth in emerging markets in the historic period. Emerging markets growth was aided by rising disposable income, stable political environment and increasing foreign investments in these countries. With unmet needs continuing to persist, societal and healthcare burden continues to increase.

Market Drivers

Advancements in diagnostics and therapeutics of central nervous system (CNS) diseases are expected to increase the treatment rate in UK. Moreover, the increasing prevalence of central nervous system disorders and the rising demand for effective therapeutics options are expected to boost market growth over the forecast years. Strong opportunities for CNS focussed drugs exists and compounding this need is the rapidly aging population and a parallel rise in Parkinson’s, Alzheimer’s, pain manifestations, cerebrovascular disorders, stroke, seizures, cognitive and memory disorders.

The scenario has created a healthy pipeline of late-stage drugs and the market is expected to benefit from rising acceptance of new therapies and new classes of drugs. Increased demand for combination therapies, growing use of generics, and launch of new Alzheimer’s drugs including anti amyloid proteins, cholinergic and nicotine receptor agonists, neuro protective drugs, vaccines, and GABA receptor modulators, better understanding of the electrochemical processes of the brain and development of disease-modifying therapies is driving growth in the antiepileptic drugs market. Volume of CNS prescriptions for chronic pain and psychiatric disorders will grow in the coming years as the burden of mental illnesses intensifies because of lifestyle and societal changes and physiological stress. The growing focus on healthcare cost containment and rationalization and legislation of policies that encourage physician prescription of generic drugs will encourage sales of generic CNS medications.

1. UK CNS Therapeutics Market Overview………………………………………………….
A. Market Size
2. Market Growth Drivers…………………………………………………………………
A. Growing focus on healthcare cost containment and rationalization and legislation of policies
B. Increased demand for combination therapies, growing use of generics, and launch of new Alzheimer’s drugs
3. Major CNS Diseases………………………………………………………………….….
A. Neurovascular diseases
B. Degenerative disease
C. Mental health trauma
D. CNS cancer
E. Others
4. UK CNS Therapeutics Market Segmentation……………………………………….
A. By Drug Class
I. Analgesics
II. Nervous system drugs
III. Anaesthetics
IV. Anti-Parkinson drugs
V. Multiple sclerosis
VI. Anti-psychotic
VII. Anti-epileptics
B. By Distribution Channel
I. Hospital pharmacies
II. Retail pharmacies/drug stores
III. Online/e-Pharmacies
5. CNS Drugs Major Products Market Share……………………………………
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. AbbVie Inc. Company overview, Product & Services, Strategies & Financials
B. Sanofi Company overview, Product & Services, Strategies & Financials
C. AstraZeneca Plc Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of CNS drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

Based on the drug type, the market is segmented into Analgesics, Nervous system drugs, Anaesthetics, Anti-Parkinson drugs, Anti-Epileptics, Anti-Psychotic and Multiple Sclerosis.

By Distribution Channel:

The CNS drugs market is also segmented by distribution channel into hospital pharmacies, retail pharmacies/drug stores and online/e-Pharmacies. The hospital pharmacy is the largest segment of the CNS drugs market by distribution channel. The e-Pharmacy segment is expected to be the fastest growing segment in the CNS drugs market.

Top 5 Major Players

The key market players are focusing on new therapies to prevent or improve the symptoms of neurological disorders. Companies such as Biogen, AbbVie Inc., F. Hoffmann-La Roche Ltd, Eli Lilly and Company, and others have their drug candidates in the last phases of the development and are expected to be commercialized in the foreseeable future. In February 2020, Biogen announced USD 2.72 billion deal with Sangamo Therapeutics to develop gene regulation therapies to treat Alzheimer’s disease. The launch of these novel drugs is anticipated to boost the market for central nervous system therapeutic.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements